131I-IPA

· Telix Pharmaceuticals (Innovations) Pty Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 131I-IPA, covering 2023-04-14 to 2023-04-14. Get the full timeline:

Most recent: Clinical Trial Update: 131I-IPA and Concurrent XRT in Recurrent GBM [Phase 1, Phase 2]